- Prasugrel
- Prasugrel hydrochloride
- Prasugrel metabolite
- 150322-73-9Ethanone,1-cyclopropyl-2-(2-fluorophenyl)-
- 150322-79-52-Propanone,3-(2-chlorophenyl)-1,1,1-trifluoro-
- 150323-35-61-Piperazinecarboxylicacid, 3-[[(1,1-dimethylethyl)amino]carbonyl]-, 1,1-dimethylethyl ester, (3S)-
- 150331-48-92(1H)-Naphthalenone,3,4-dihydro-5,7-dimethyl-
- 150332-35-7Spirostan-11-one,3-[(4-O-b-D-glucopyranosyl-b-D-glucopyranosyl)oxy]-, (3b,5a,25R)-
- 150347-56-1Spiro[isobenzofuran-1(3H),9'-[9H]xanthene]-ar-carboxylicacid, 3',6'-(dimethylamino)-3-oxo- (9CI)
- 150347-58-32,5-Pyrrolidinedione,1-[[[3,11-dihydroxy-3'-oxospiro[7H-dibenzo[c,h]xanthene-7,1'(3'H)-isobenzofuran]-5'(or6')-yl]carbonyl]oxy]- (9CI)
- 150347-59-4Spiro[isobenzofuran-1(3H),9'-[9H]xanthene]-ar-carboxylicacid, 3',6'-bis(acetyloxy)-3-oxo-, 2,5-dioxo-1-pyrrolidinyl ester
- 150349-36-3Carbamic acid,N-(3-aminopropyl)-N-methyl-, 1,1-dimethylethyl ester
- 1503-49-7Benzonitrile,4-benzoyl-
Hot Products
- 184475-35-2Gefitinib
- 179324-69-7Bortezomib
- 366789-02-8Rivaroxaban
- 56038-13-2Sucralose
- 152460-10-1N-(5-Amino-2-methylphenyl)-4-(3-pyridyl)-2-pyrimidineamine
- 530-62-11,1'-Carbonyldiimidazole
- 165800-03-3Acetamide,N-[[(5S)-3-[3-fluoro-4-(4-morpholinyl)phenyl]-2-oxo-5-oxazolidinyl]methyl]-
- 183319-69-9Erlotinib hydrochloride
- 104987-11-3Tacrolimus
- 141-53-7Sodium formate
- 8001-54-5Quaternary ammonium compounds, alkylbenzyldimethyl, chlorides
- 9003-39-8Povidone
- 10161-34-9Trenbolone acetate
- 402957-28-2Telaprevir
- 68-19-9Cyanocobalamin
|
Basic Information |
|
Post buying leads |
|
Suppliers |
|
Cas Database |
| Name |
Prasugrel |
EINECS | 801-962-1 |
| CAS No. | 150322-43-3 | Density | 1.347 g/cm3 |
| PSA | 74.85000 | LogP | 3.82890 |
| Solubility | N/A | Melting Point |
120.0 to 124.0 °C |
| Formula | C20H20FNO3S | Boiling Point | 493.5 °C at 760 mmHg |
| Molecular Weight | 373.448 | Flash Point | 252.3 °C |
| Transport Information | N/A | Appearance | White solid |
| Safety | 24/25 | Risk Codes | N/A |
| Molecular Structure |
|
Hazard Symbols | N/A |
| Synonyms |
2-[2-(Acetyloxy)-6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl]-1-cyclopropyl-2-(2-fluorophenyl)ethanone;CS 747;CS-747;LY 640315;UNII-34K66TBT99; |
Article Data | 51 |
Prasugrel Synthetic route
- 150322-38-6
5-(2-cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl)-5,6,7,7a-tetrahydrothieno[3,2-c]pyridin-2(4H)-one
- 75-36-5
acetyl chloride
- 150322-43-3
prasugel
| Conditions | Yield |
|---|---|
| Stage #1: 5-(2-cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl)-5,6,7,7a-tetrahydrothieno[3,2-c]pyridin-2(4H)-one; acetyl chloride With acetic acid In toluene at 20℃; Inert atmosphere; Stage #2: With sodium hydrogencarbonate In water; toluene | 99% |
| With D201 macroporous strong basic styrene anion exchange resin, average particle diameter: 1.0 mm In tetrahydrofuran at 45℃; for 1.5h; Reagent/catalyst; Temperature; | 87.1% |
- 952340-38-4
2-(tert-butyldimethylsilyloxy)-5-(α-cyclopropylformyl-2-fluorobenzyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine
- 75-36-5
acetyl chloride
- 150322-43-3
prasugel
| Conditions | Yield |
|---|---|
| Stage #1: 2-(tert-butyldimethylsilyloxy)-5-(α-cyclopropylformyl-2-fluorobenzyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine; acetyl chloride With acetic acid In toluene at 20℃; Inert atmosphere; Stage #2: With sodium hydrogencarbonate In water; toluene Product distribution / selectivity; | 99% |
- 150322-38-6
5-(2-cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl)-5,6,7,7a-tetrahydrothieno[3,2-c]pyridin-2(4H)-one
- 108-24-7
acetic anhydride
- 150322-43-3
prasugel
| Conditions | Yield |
|---|---|
| With triethylamine; sodium hydroxide In water; ethyl acetate at 7 - 50℃; pH=2.8; Temperature; pH-value; | 92.58% |
| With triethylamine In dichloromethane for 3h; Reflux; | 90.2% |
| With N-ethyl-N,N-diisopropylamine In dichloromethane at 0℃; for 4h; Temperature; Reagent/catalyst; Solvent; | 83.2% |
- 952340-38-4
2-(tert-butyldimethylsilyloxy)-5-(α-cyclopropylformyl-2-fluorobenzyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine
- 108-24-7
acetic anhydride
- 150322-43-3
prasugel
| Conditions | Yield |
|---|---|
| Stage #1: 2-(tert-butyldimethylsilyloxy)-5-(α-cyclopropylformyl-2-fluorobenzyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine With dmap; triethylamine In acetone at 0℃; for 0.166667h; Stage #2: acetic anhydride In acetone Solvent; Temperature; | 90% |
| With triethylamine; dmap In acetonitrile at -15℃; for 1h; | |
| Stage #1: 2-(tert-butyldimethylsilyloxy)-5-(α-cyclopropylformyl-2-fluorobenzyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine With dmap; triethylamine In acetonitrile at 20℃; for 0.25h; Stage #2: acetic anhydride In acetonitrile at 20℃; | |
| With dmap; triethylamine In acetonitrile at 0℃; | |
| With dmap; triethylamine In acetonitrile at -4 - -3℃; for 2.25h; |
- 108-24-7
acetic anhydride
- 150322-43-3
prasugel
| Conditions | Yield |
|---|---|
| With sodium hydride In N,N-dimethyl-formamide at 0℃; | 85% |
| With sodium hydride In N,N-dimethyl-formamide; mineral oil at 0 - 20℃; for 1h; Inert atmosphere; | 85% |
| With N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide at 15 - 25℃; | 46% |
| With N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide at 20℃; for 1h; |
- 1243654-57-0
5-(α-cyclopropylcarbonyl-2-fluorobenzyl)-2-oxo-2,4,5,6,7,7a-hexahydrothieno[3,2-c]pyridine hydrobromide
- 108-24-7
acetic anhydride
- 150322-43-3
prasugel
| Conditions | Yield |
|---|---|
| Stage #1: 5-(α-cyclopropylcarbonyl-2-fluorobenzyl)-2-oxo-2,4,5,6,7,7a-hexahydrothieno[3,2-c]pyridine hydrobromide With triethylamine In dichloromethane at 0 - 5℃; for 0.5h; Stage #2: acetic anhydride In dichloromethane | 73% |
| Stage #1: 5-(α-cyclopropylcarbonyl-2-fluorobenzyl)-2-oxo-2,4,5,6,7,7a-hexahydrothieno[3,2-c]pyridine hydrobromide With triethylamine In dichloromethane at 25 - 30℃; for 0.25h; Stage #2: acetic anhydride In dichloromethane at 0 - 5℃; for 6h; | |
| Stage #1: 5-(α-cyclopropylcarbonyl-2-fluorobenzyl)-2-oxo-2,4,5,6,7,7a-hexahydrothieno[3,2-c]pyridine hydrobromide With triethylamine In dichloromethane at 25 - 30℃; for 0.25h; Stage #2: acetic anhydride In dichloromethane at 0 - 5℃; for 6h; | |
| With triethylamine In dichloromethane at 0℃; for 3.5h; |
- 389574-20-3
prasugrel maleate salt
- 150322-43-3
prasugel
| Conditions | Yield |
|---|---|
| With sodium carbonate In water; ethyl acetate for 0.25h; pH=6.8; Solvent; | 68.5% |
| Conditions | Yield |
|---|---|
| With zinc sulfide; acetic acid; triethylamine In tetrahydrofuran at -10 - 55℃; for 8h; Green chemistry; | 68.5% |
- 150322-38-6
5-(2-cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl)-5,6,7,7a-tetrahydrothieno[3,2-c]pyridin-2(4H)-one
- 150322-43-3
prasugel
| Conditions | Yield |
|---|---|
| With acetic anhydride In N-methyl-acetamide; mineral oil | 65% |
| With acetic anhydride; sodium hydride In N,N-dimethyl-formamide; mineral oil at 0 - 20℃; for 3.5h; | 65% |
| Multi-step reaction with 2 steps 1.1: hydrogen bromide / water; acetone / 1 h / 0 - 5 °C 2.1: triethylamine / dichloromethane / 0.25 h / 25 - 30 °C 2.2: 6 h / 0 - 5 °C View Scheme |
- 204205-33-4
2-bromo-1-cyclopropyl-2-(2-fluorophenyl)ethanone
- 178688-49-8
5,6,7,7a-tetrahydro-4H-thieno[3,2-c]pyridin-2-one p-toluenesulfonate
- 108-24-7
acetic anhydride
- 150322-43-3
prasugel
| Conditions | Yield |
|---|---|
| Stage #1: 2-bromo-1-cyclopropyl-2-(2-fluorophenyl)ethanone; 5,6,7,7a-tetrahydro-4H-thieno[3,2-c]pyridin-2-one p-toluenesulfonate With N-ethyl-N,N-diisopropylamine In acetonitrile at 30℃; for 0.5h; Stage #2: acetic anhydride With N-ethyl-N,N-diisopropylamine; dmap In acetonitrile Product distribution / selectivity; | 60.3% |
Prasugrel Chemical Properties
Molecular structure of Prasugrel (CAS NO.150322-43-3) is:
Product Name: Prasugrel
CAS Registry Number: 150322-43-3
IUPAC Name: [5-[2-cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl]-6,7-dihydro-4H-thieno[3,2-c]pyridin-2-yl] acetate
Molecular Weight: 373.441103 [g/mol]
Molecular Formula: C20H20FNO3S
XLogP3-AA: 3.6
H-Bond Donor: 0
H-Bond Acceptor: 5
Surface Tension: 56.7 dyne/cm
Density: 1.347 g/cm3
Flash Point: 252.3 °C
Enthalpy of Vaporization: 76.06 kJ/mol
Boiling Point: 493.5 °C at 760 mmHg
Vapour Pressure: 7.01E-10 mmHg at 25°C
Classification Code: Platelet Aggregation Inhibitors
Prasugrel History
Prasugrel (marketing name Effient in the US and Efient in EU) is a novel platelet inhibitor developed by Daiichi Sankyo Co. and produced by Ube and currently under clinical development in cooperation with Eli Lilly and Company for acute coronary syndromes planned for percutaneous coronary intervention (PCI). The U.S. Food and Drug Administration approved Effient tablets for the reduction of thrombotic cardiovascular events in July 10, 2009.
Prasugrel Uses
Prasugrel (CAS NO.150322-43-3) can be used as a novel platelet inhibitor.And it is a P2Y(12) receptor antagonist with antiplatelet activity.
Prasugrel Specification
Prasugrel , its cas register number is 150322-43-3. It also can be called 2-[2-(Acetyloxy)-6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl]-1-cyclopropyl-2-(2-fluorophenyl)ethanone .It is a member of the thienopyridine class of ADP receptor inhibitors. And it produces inhibition of platelet aggregation to 20 μM or 5 μM ADP, as measured by light transmission aggregometry.
What can I do for you?
Get Best Price
